Wyeth responds to criticism.
作者信息
Stiles Gary M
出版信息
Md Med. 2005 Autumn;6(4):5, 7-8; author reply 8.
PMID:16454430
Abstract
摘要
相似文献
1
Wyeth responds to criticism.惠氏回应批评。
Md Med. 2005 Autumn;6(4):5, 7-8; author reply 8.
2
Wyeth Pharmaceutical's perspective on vaccine production.惠氏制药公司对疫苗生产的看法。
Md Med. 2005 Winter;6(1):22-3.
3
The fragility of the U.S. vaccine supply.美国疫苗供应的脆弱性。
N Engl J Med. 2004 Dec 2;351(23):2443-7. doi: 10.1056/NEJMsb033394.
4
The National Childhood Vaccine Injury Act and the supreme court's interpretation.《国家儿童疫苗伤害法案》及最高法院的解释
Virtual Mentor. 2012 Jan 1;14(1):31-4. doi: 10.1001/virtualmentor.2012.14.1.hlaw1-1201.
5
Triage in the nation's medicine cabinet: the puzzling scarcity of vaccines and other drugs.国家药柜中的分诊：疫苗及其他药物令人费解的短缺情况。
S C Law Rev. 2002 Winter;54(2):371-403.
6
Determinants of vaccine supply.疫苗供应的决定因素。
Natl Bur Econ Res Bull Aging Health. 2011(3):2-3.
7
Medicine. The intangible value of vaccination.医学。疫苗接种的无形价值。
Science. 2002 Aug 9;297(5583):937-9. doi: 10.1126/science.1075173.
8
The politics of vaccine production.疫苗生产的政治学
Md Med. 2005 Winter;6(1):19-22.
9
Tempered enthusiasm. Drug-safety law needs more teeth, patient-safety advocates say.适度的热情。患者安全倡导者表示，药品安全法需要更有力的手段。
Mod Healthc. 2007 Oct 8;37(40):16.
10
Markets and public health: pushing and pulling vaccines into production.
Am J Bioeth. 2006 May-Jun;6(3):3-6. doi: 10.1080/15265160600781504.
Zotero 插件